NCT01572844View on ClinicalTrials.gov

Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Calcinosis
Interventions
DEVICE

Fractionated Carbon Dioxide (FCO2) Laser

At each treatment visit, a 2 X 2 cm (+/- 1 cm) area of the target calcinosis lesions will be treated with one pass of the Candela QuadraLase (TM) FCO2 laser. Patients will receive a total of 8-10 treatments over a 6 month period.

DRUG

Sodium thiosulfate

Following treatment with FCO2 laser, 4 ml of 5% Sodium Thiosulfate solution will be applied to the treatment site only. Subjects will receive a total of 8-10 treatments over a 6 month period.

Trial Locations (1)

20037

The George Washington University Medical Faculty Associates Departments of Dermatology and Rheumatology, Washington D.C.

All Listed Sponsors
lead

Alison Ehrlich

OTHER

NCT01572844 - Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis | Biotech Hunter | Biotech Hunter